Immunogenicity of replication-deficient vesicular stomatitis virus based rabies vaccine in mice

References

• Abreu-Mota T, Hagen KR, Cooper K, Jahrling PB, Tan G, Wirblich C, Johnson RF, Schnell MJ. 2018. Non-neutralizing antibodies elicited by recombinant Lassa-Rabies vaccine are critical for protection against Lassa fever. Nat Commun. 9(1):4223.
   PubMed Web of Science ®Google Scholar
• Albertini AA, Ruigrok RW, Blondel D. 2011. Rabies virus transcription and replication. Adv Virus Res. 79:1–22.
   PubMed Web of Science ®Google Scholar
• Amann R, Rohde J, Wulle U, Conlee D, Raue R, Martinon O, Rziha H-J. 2013. A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein. J Virol. 87(3):1618–1630.
   PubMed Web of Science ®Google Scholar
• Armbruster N, Jasny E, Petsch B. 2019. Advances in RNA vaccines for preventive indications: a case study of a vaccine against rabies. Vaccines (Basel). 7(4). Sep 27https://doi.org/10.3390/vaccines7040132.
   Google Scholar
• Banyard AC, Horton DL, Freuling C, Muller T, Fooks AR. 2013. Control and prevention of canine rabies: the need for building laboratory-based surveillance capacity. Antiviral Res. 98(3):357–364.
   PubMed Web of Science ®Google Scholar
• Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J. 2000. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med. 192(2):271–280.
   PubMed Web of Science ®Google Scholar
• Boes M, Esau C, Fischer MB, Schmidt T, Carroll M, Chen J. 1998. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J Immunol. 160(10):4776–4787.
   PubMed Web of Science ®Google Scholar
• Chen T, Zhou X, Qi Y, Mi L, Sun X, Zhang S, Liu Y, Olson V, Qiu W, Wu X, et al. 2019. Feline herpesvirus vectored-rabies vaccine in cats: a dual protection. Vaccine. 37(16):2224–2231.
   PubMed Web of Science ®Google Scholar
• Chulasugandha P, Khawplod P, Havanond P, Wilde H. 2006. Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children. Vaccine. 24(9):1478–1482.
   PubMed Web of Science ®Google Scholar
• Cliquet F, Picard-Meyer E. 2004. Rabies and rabies-related viruses: a modern perspective on an ancient disease. Rev Sci Tech. 23(2):625–642.
   PubMed Web of Science ®Google Scholar
• Cobleigh MA, Bradfield C, Liu Y, Mehta A, Robek MD. 2012. The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate. J Virol. 86(8):4253–4261.
   PubMed Web of Science ®Google Scholar
• DeBuysscher BL, Scott D, Marzi A, Prescott J, Feldmann H. 2014. Single-dose live-attenuated Nipah virus vaccines confer complete protection by eliciting antibodies directed against surface glycoproteins. Vaccine. 32(22):2637–2644.
   PubMed Web of Science ®Google Scholar
• Diamond MS, Sitati EM, Friend LD, Higgs S, Shrestha B, Engle M. 2003. A critical role for induced IgM in the protection against West Nile virus infection. J Exp Med. 198(12):1853–1862.
   PubMed Web of Science ®Google Scholar
• Dong F, Li D, Wen D, Li S, Zhao C, Qi Y, Jangra RK, Wu C, Xia D, Zhang X, et al. 2019. Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus. NPJ Vaccines. 4(1):5.
   PubMedGoogle Scholar
• Dorfmeier CL, Lytle AG, Dunkel AL, Gatt A, McGettigan JP. 2012. Protective vaccine-induced CD4(+) T cell-independent B cell responses against rabies infection. J Virol. 86(21):11533–11540.
   PubMed Web of Science ®Google Scholar
• Dorfmeier CL, Shen S, Tzvetkov EP, McGettigan JP. 2013. Reinvestigating the role of IgM in rabies virus postexposure vaccination. J Virol. 87(16):9217–9222. Aug
   PubMed Web of Science ®Google Scholar
• Ertl HCJ. 2019. New rabies vaccines for use in humans. Vaccines (Basel). 7(2):54.
   Web of Science ®Google Scholar
• Finkelman FD, Holmes J, Katona IM, Urban JF, Beckmann MP, Park LS, Schooley KA, Coffman RL, Mosmann TR, Paul WE, et al. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol. 8(1):303–333.
   PubMedGoogle Scholar
• Flamand A, Raux H, Gaudin Y, Ruigrok RW. 1993. Mechanisms of rabies virus neutralization. Virology. 194(1):302–313.
   PubMed Web of Science ®Google Scholar
• Fooks AR, Cliquet F, Finke S, Freuling C, Hemachudha T, Mani RS, Müller T, Nadin-Davis S, Picard-Meyer E, Wilde H, et al. 2017. Rabies. Nat Rev Dis Primers. 3(1):17091.
   PubMedGoogle Scholar
• Fooks AR, Johnson N, Brookes SM, Parsons G, McElhinney LM. 2003. Risk factors associated with travel to rabies endemic countries. J Appl Microbiol. 94(Suppl):31–6S.
   Google Scholar
• Hampson K, Coudeville L, Lembo T, Sambo M, Kieffer A, Attlan M, Barrat J, Blanton JD, Briggs DJ, Cleaveland S, et al.; on behalf of the Global Alliance for Rabies Control Partners for Rabies Prevention. 2015. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis. 9(4):e0003709.
   PubMed Web of Science ®Google Scholar
• Hangartner L, Zinkernagel RM, Hengartner H. 2006. Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol. 6(3):231–243.
   PubMed Web of Science ®Google Scholar
• Kamoltham T, Khawplod P, Wilde H. 2002. Rabies intradermal post-exposure vaccination of humans using reconstituted and stored vaccine. Vaccine. 20(27–28):3272–3276.
   PubMed Web of Science ®Google Scholar
• Kamoltham T, Thinyounyong W, Phongchamnaphai P, Phraisuwan P, Khawplod P, Banzhoff A, Malerczyk C. 2007. Pre-exposure rabies vaccination using purified chick embryo cell rabies vaccine intradermally is immunogenic and safe. J Pediatr. 151(2):173–177.
   PubMed Web of Science ®Google Scholar
• Kopf M, Brombacher F, Bachmann MF. 2002. Role of IgM antibodies versus B cells in influenza virus-specific immunity. Eur J Immunol. 32(8):2229–2236.
   PubMed Web of Science ®Google Scholar
• Madhusudana SN, Subha S, Thankappan U, Ashwin YB. 2012. Evaluation of a direct rapid immunohistochemical test (dRIT) for rapid diagnosis of rabies in animals and humans. Virol Sin. 27(5):299–302.
   PubMedGoogle Scholar
• Marzi A, Feldmann F, Geisbert TW, Feldmann H, Safronetz D. 2015. Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses. Emerg Infect Dis. 21(2):305–307.
   PubMed Web of Science ®Google Scholar
• Moore SM, Hanlon CA. 2010. Rabies-specific antibodies: measuring surrogates of protection against a fatal disease. PLoS Negl Trop Dis. 4(3):e595e595.
   Web of Science ®Google Scholar
• Nandi S, Kumar M. 2010. Development in immunoprophylaxis against rabies for animals and humans. Avicenna J Med Biotechnol. 2(1):3–21.
   PubMedGoogle Scholar
• Park J-E, Li K, Barlan A, Fehr AR, Perlman S, McCray PB, Gallagher T Jr. 2016. Proteolytic processing of Middle East respiratory syndrome coronavirus spikes expands virus tropism. Proc Natl Acad Sci USA. 113(43):12262–12267.
   PubMed Web of Science ®Google Scholar
• Racine R, Winslow GM. 2009. IgM in microbial infections: taken for granted? Immunol Lett. 125(2):79–85.
   PubMed Web of Science ®Google Scholar
• Ramya R, Mohana Subramanian B, Sivakumar V, Senthilkumar RL, Sambasiva Rao KR, Srinivasan VA. 2011. Expression and solubilization of insect cell-based rabies virus glycoprotein and assessment of its immunogenicity and protective efficacy in mice. Clin Vaccine Immunol. 18(10):1673–1679.
   PubMedGoogle Scholar
• Rupprecht CE, Nagarajan T, Ertl H. 2016. Current status and development of vaccines and other biologics for human rabies prevention. Expert Rev Vaccines. 15(6):731–749.
   PubMed Web of Science ®Google Scholar
• Schnell MJ, Johnson JE, Buonocore L, Rose JK. 1997. Construction of a novel virus that targets HIV-1-infected cells and controls HIV-1 infection. Cell. 90(5):849–857.
   PubMed Web of Science ®Google Scholar
• Smith JS, Yager PA, Baer GM. 1973. A rapid reproducible test for determining rabies neutralizing antibody. Bull World Health Organ. 48(5):535–541.
   PubMed Web of Science ®Google Scholar
• Snapper CM, Paul WE. 1987. Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science. 236(4804):944–947.
   PubMed Web of Science ®Google Scholar
• Tober R, Banki Z, Egerer L, Muik A, Behmuller S, Kreppel F, Greczmiel U, Oxenius A, von Laer D, Kimpel J, et al. 2014. VSV-GP: a potent viral vaccine vector that boosts the immune response upon repeated applications. J Virol. 88(9):4897–4907.
   PubMed Web of Science ®Google Scholar
• Wang C, Dulal P, Zhou X, Xiang Z, Goharriz H, Banyard A, Green N, Brunner L, Ventura R, Collin N, et al. 2018. A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis. PLoS Negl Trop Dis. 12(10):e0006870.
   PubMed Web of Science ®Google Scholar
• Wang X, Fang Z, Xiong J, Yang K, Chi Y, Tang X, Ma L, Zhang R, Deng F, Lan K, et al. 2019. A chimpanzee adenoviral vector-based rabies vaccine protects beagle dogs from lethal rabies virus challenge. Virology. 536:32–38.
   PubMed Web of Science ®Google Scholar
• Wu F, Fan X, Yue Y, Xiong S, Dong C. 2014. A vesicular stomatitis virus-based mucosal vaccine promotes dendritic cell maturation and elicits preferable immune response against coxsackievirus B3 induced viral myocarditis. Vaccine. 32(31):3917–3926.
   PubMed Web of Science ®Google Scholar
• Zhu S, Guo C. 2016. Rabies control and treatment: from prophylaxis to strategies with curative potential. Viruses. 8(11):279.
   Web of Science ®Google Scholar
• Zinkernagel RM, Adler B, Holland JJ. 1978. Cell-mediated immunity to vesicular stomatitis virus infections in mice. Expl Cell Biol. 46(1-2):53–70.
   PubMedGoogle Scholar